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Abstract 
Background: Asthma exacerbations are one of the most common medical reasons for 
children to be brought to the hospital emergency department (ED). Various prediction models 
have been proposed to support diagnosis of exacerbations and evaluation of their severity. 
Objectives: First, to evaluate prediction models constructed from data using machine 
learning techniques and to select the best performing model. Second, to compare predictions 
from the selected model with predictions from the Pediatric Respiratory Assessment Measure 
(PRAM) score, and predictions made by ED physicians. 
Design: A two-phase study conducted in the ED of an academic pediatric hospital. In phase 1 
data collected prospectively using paper forms was used to construct and evaluate five 
prediction models, and the best performing model was selected. In phase 2, data collected 
prospectively using a mobile system was used to compare the predictions of the selected 
prediction model with those from PRAM and ED physicians.  
Measurements: Area under the receiver operating characteristic curve and accuracy in phase 
1; accuracy, sensitivity, specificity, positive and negative predictive values in phase 2. 
Results: In phase 1 prediction models were derived from a data set of 240 patients and 
evaluated using 10-fold cross validation. A naive Bayes (NB) model demonstrated the best 
performance and it was selected for phase 2. Evaluation in phase 2 was conducted on data 
from 82 patients. Predictions made by the NB model were less accurate than the PRAM score 
and physicians (accuracy of 70.7%, 73.2% and 78.0% respectively), however, according to 
McNemar’s test it is not possible to conclude that the differences between predictions are 
statistically significant. 
Conclusion: Both the PRAM score and the NB model were less accurate than physicians. 
The NB model can handle incomplete patient data and as such may complement the PRAM 
score. However, it requires further research to improve its accuracy.  
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1. Introduction 
Asthma is the leading chronic disease in childhood and asthma exacerbations are one 
of the most common medical reasons for children to be brought to the hospital emergency 
department (ED). These visits, and the subsequent hospitalizations required by a large 
proportion of patients, account for more than 60% of all costs of asthma care [1]. 
Clinical practice guidelines (CPGs) for pediatric asthma, for example the EPR-3 CPG 
developed by the National Heart, Lung and Blood Institute [2], define four categories of 
asthma control severity, three categories of exacerbation severity (mild, moderate, and 
severe) and a subset of life-threatening severity. In this study we are not concerned with 
asthma control severity, as it looks at how symptomatic a chronically ill patient is on a day-
to-day basis. Instead, we are concerned solely with the severity of exacerbations, excluding 
life-threatening situations. In the academic center where our study was conducted – the 
Children’s Hospital of Eastern Ontario (CHEO) –  patients with a mild exacerbation are 
usually discharged home after a brief course of treatment (typically less than 4 hours in the 
ED), patients with a moderate exacerbation undergo prolonged and more aggressive 
treatment in the ED or in an observation unit (typically 4-16 hours in total), and patients with 
a severe exacerbation receive maximal stabilization therapy before being transferred to an in-
patient hospital bed for ongoing therapy (or spend typically over 16 hours in the ED). These 
lengths of stay are generally in line with data reported by others, for example [1,3]. 
It is important that the severity of a child’s asthma exacerbation is determined as soon 
as possible, so that appropriate therapies are prescribed and provided in a timely fashion [4]. 
Underestimation of the severity of the exacerbation results in inadequate treatment so that 
discharge is delayed, or in premature discharge and possible need for a return visit. 
Conversely, overestimation results in patients receiving unnecessary therapies and 
unnecessarily occupying ED resources when they could be safely managed at home.  
According to a review by Sanders and Aronsky [5], the development of decision 
models for detecting and evaluating asthma and its exacerbations is a very active research 
field. These models are usually developed from data using statistical or machine learning 
methods. There are studies [6-8] that compare the performance of these two groups of 
methods in a variety of settings. While some of the reported results are more conclusive than 
the others, a prevailing view is that it is difficult to establish general guidelines for selecting a 
specific method [9].  
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Building on our earlier research [10] in this paper we apply machine learning to 
develop models for predicting severity of asthma exacerbation for patients already diagnosed 
with asthma and presenting to the ED. Thus, we contribute to the research on computer-based 
support for asthma management as advocated by Sanders and Aronsky [5] and expand the 
line of research presented by Dexheimer et al. [11] and Sanders and Aronsky [12] by 
focusing on exacerbation severity assessment during the course of asthma management in the 
ED. Specifically, the purpose of our study is to answer the following research questions:   What is the best performing prediction model (evaluation measures are presented in 
details in Section 3.2.1) that can be used to evaluate the severity of pediatric asthma 
exacerbations early in the ED visit?   How does the prediction model’s performance compare with predictions derived by the 
Pediatric Respiratory Assessment Measure (PRAM) score [13] and those made by 
physicians? 
We consider the PRAM score as a comparator because it was in use in the ED of 
CHEO where the research took place.  
2. Literature review 
Sanders and Aronsky define four domains in biomedical informatics related to asthma 
management: detection and diagnosis, monitoring and prevention, patient education, and 
therapy of acute or chronic asthma [5]. In this review we are concerned with the first domain, 
as it is directly related to our research. Specifically, the biomedical informatics research on 
detection and diagnosis of asthma is concerned with two important and complementary lines 
of research: identifying asthma and its exacerbations, and evaluating their severity [5].  
The first line of research is well represented by work conducted at the Vanderbilt 
University Medical Canter. Sanders and Aronsky [14] presented a Bayesian network model 
to identify patients eligible for an asthma CPG. The model was constructed using expert 
knowledge and its parameters were learned from data describing 3017 patient visits. The 
model was tested on an independent test set with 1006 visits, where it demonstrated the value 
for an area under the receiver operating characteristic (ROC) curve (AUC) of 0.96 (notions of 
the ROC and AUC are described in detail in Section 3.2.1). The Bayesian network was 
applied in the asthma detection system [1]. Among 1100 patients identified by the system as 
having asthma exacerbation, the diagnosis was confirmed for 704 patients, thus yielding an 
accuracy of 64%. Also Sanders et al. [15] described a rule-based algorithm for identifying 
asthma exacerbations in the ED. The rules were defined by the experts and used patient data 
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available in electronic form during triage. The algorithm was tested on a data set with 1835 
ED visits and achieved a sensitivity of 44.8% and specificity of 91.6% (AUC was not 
reported in the paper). 
Dexheimer et al. [11] expanded an earlier study by Sanders et al. [14] by applying 
several machine learning techniques to previously collected data. Specifically, they 
considered a neural network model, a support vector machine model, a Gaussian process (a 
probabilistic extension to the neural network) and an automatically constructed Bayesian 
network. When verified on the test set, these models demonstrated AUC ranging from of 0.94 
(the neural network model) to 0.96 (the Gaussian process and the Bayesian network model). 
The AUC for the support vector machine was not reported. 
Most research on evaluation of asthma exacerbation severity is concerned with 
asthma CPGs and asthma severity scores. For example, Powell et al. [16] described a study 
where they checked adherence of ED physicians classifying asthma exacerbation severity to 
the CPG developed by the National Asthma Council Australia. They reported that the 
adherence was only moderate (kappa = 0.48) with physicians underestimating the severity 
(the authors did not report the accuracy of severity predictions). Limited compliance of 
physicians with CPGs is reported also by Eccles et al. [17]. Another example of a CPG 
supporting exacerbation severity evaluation is the EPR-3 CPG [2]. It was implemented in a 
system for assessment asthma severity and management in a clinic setting [18]. The system 
was tested in a cohort study, where it provided accurate predictions of asthma severity for 63 
out of 100 patients. 
Selected asthma exacerbation severity scores have been reviewed by Birken et al. 
[19]. The authors pointed at the lack of formal development processes for scoring algorithms. 
Moreover, the review did not produce conclusive results with regards to the clinical value of 
asthma scores. While most scores are focused on responsiveness (changes in the score values 
correspond to the changes in the state of an asthmatic patient), there are some that have 
discriminative capabilities and can be used as severity predictors.  Examples of such scores 
include PRAM [13] (discussed in Section 3.3) and Pediatric Asthma Severity Score (PASS) 
[20]. Prediction capabilities of these two scores were evaluated by Gouin et al. [21], who 
used the length of stay as a proxy of exacerbation severity and distinguished between patients 
who stayed in the ED < 6 hours, and those who stayed ≥ 6 hours and/or were admitted to the 
ward. Both PRAM and PASS were applied to 283 patients and the AUC for PRAM was 0.69 
and for PASS it was 0.70. 
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A different approach to evaluating exacerbation severity is presented by Zolnoori et 
al. [22], who describe a system using fuzzy rules. There are two types of rules – evaluating 
rules that describe relationships between symptoms and laboratory results and the 
exacerbation severity, and meta-rules that control the inference process. Both types of rules 
rely on expert knowledge – they were derived by experts or from a medical literature. The 
system was tested on 25 asthmatic patients and its outcomes were compared to the outcomes 
of the physicians. While both matched perfectly (kappa = 1) it is important to note that no 
gold standard measure was used in this comparison. 
A system for evaluating asthma severity was presented by Sefion et al. [23]. Their 
ADEMA system used an instance-based model that included 190 cases and in a leave-one out 
test it demonstrated a prediction accuracy of 61.0% for asthma severity and 71.2% for 
therapy respectively (no AUC values were reported in the paper).   
Machine learning techniques were also applied in a study by Farion et al. [10], where 
a decision tree model was constructed and verified using data transcribed retrospectively 
from paper charts. The learning data set of 239 patient visits was preprocessed by removing 
questionable cases (a simplified version of the PRAM score was used for this purpose) and 
by contextual normalization of age-dependent numerical attributes. The decision model was 
tested on an independent test set comprised of 123 patient visits, where it demonstrated AUC 
of 0.83. A logistic regression model constructed and evaluated using the same data sets was 
less accurate and produced AUC of 0.74.  
The study described in this paper adds to the body of knowledge on applying machine 
learning methods to build prediction models for asthma exacerbations. Moreover, to the best 
of our knowledge, it is the first study that directly compares machine learning prediction 
models with asthma exacerbation severity scores, thus providing a better insight into the 
strengths and weaknesses of both types of predictors. 
3. Methods 
3.1. Study setting 
The study described in this paper was conducted at CHEO (Ottawa, Ontario, Canada). 
Our study site is a tertiary, academic pediatric hospital with about 60,000 annual ED visits. It 
has the only pediatric ED serving an estimated population of over 450,000 children in Eastern 
Ontario and Western Quebec, staffed with emergency physicians (staff EPs), fellows, and 
residents. 
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Information management in the ED is handled by an admission-discharge-transfer 
system (Epic) and an ED information system (Allscripts ED) that exchange information using 
HL7 messages. There is a secure wireless network that provides mobile access to these 
systems as well as to vital signs monitors.  
3.2. Study design and population 
The CHEO Research Ethics Board approved our study; the study population included 
pediatric asthma patients who satisfied the inclusion and exclusion criteria listed in Table I 
when they presented to the ED. The patients were categorized by exacerbation severity that 
distinguished between mild and moderate/severe exacerbations. Such categorization 
corresponds to different therapies required by patients with mild and moderate/severe 
exacerbations – the latter includes patients who are given systemic corticosteroids and 
anticholinergics as early as possible to reduce the length of stay and requirement for hospital 
admission [4]. Thus, therapeutically it is reasonable to combine moderate and severe 
exacerbations into a single category. 
The study was conducted in two phases. In phase 1 we prospectively collected patient 
data using structured paper forms, applied machine learning techniques to the collected data 
in order to construct and evaluate several prediction models, and selected the best performing 
model. In phase 2 we collected a new set of patient data using a mobile system, applied the 
prediction model selected in phase 1 to this data set, and compared the predictive 
performance of the model to the performance of the PRAM score and physicians. Both 
phases are described in detail in Section 3.2.1 and 3.2.2 respectively. 
In phase 1 the inclusion/exclusion criteria (see Table I) were applied by a triage nurse, 
and in phase 2 they were applied automatically to HL7 admission messages. Potentially 
eligible patients were flagged (color stickers in phase 1, electronically in phase 2) and 
enrolled at the discretion of attending physicians (staff EPs, fellows and residents). This 
enrollment was subject to many factors including current ED workload, physician’s 
willingness to follow the study protocol, and external circumstances (such as the H1N1 
regime in place). Approached patients (parents) were asked to provide informed verbal 
consent to participate in the study, and once consent was obtained, a patient was again re-
checked by the physician for eligibility. 
When collecting data (paper forms or a mobile system) attending physicians were 
instructed to collect information related to patient history, the current asthma exacerbation 
episode, and conducted assessments – primary (triage) or secondary (repeated). Clinical 
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attributes considered during data collection are presented in Table II. We need to note that 
values for the last group of attributes (#23-32) may have been recorded multiple times for all 
secondary assessments. 
3.2.1. Phase 1 
In phase 1 (conducted between November 2006 and May 2007), prospective data was 
collected using paper forms that were attached to charts of eligible patients. Primary 
assessments were recorded by the triage nurse first, assessing the patient on arrival; 
secondary assessments were collected at various times during the visit by the treating 
physician or nurse. Patient history was collected once by the physician. When feasible, paired 
observations were conducted by two observers to assess interobserver reliability. From the 
data collected or recorded in the patient`s chart, the PRAM score at triage was determined.  
Treating physicians were asked to rate the patient`s exacerbation severity and predicted 
length of stay, as mild (less than 4 hours), moderate (4-16 hours), or severe (greater than 16 
hours or requiring admission). 
A research assistant (RA) routinely audited the collected data to identify and address 
potential problems (i.e., lack of relevant data). At 10-14 days after the visit, each enrolled 
patient (or parent) was contacted by phone to inquire about the patient’s condition. The 
complete patient chart was also independently reviewed. All this information was used to 
determine the final exacerbation severity category for the visit. 
The collected data set was processed to minimize the number of missing values 
associated with the assessment attributes and to limit the number of secondary assessments 
associated with each patient. If a recorded assessment had missing data, we used data from 
the corresponding paired assessment to fill in these values. To identify the secondary 
assessment that would be used for analysis, we determined the average time from primary to 
first secondary assessment and calculated the standard deviation. For each patient`s data, the 
assessment closest to this average time was used, providing that it occurred within the time 
window of one standard deviation before or after the average [average time ± standard 
deviation]. Patient records without a secondary assessment within this window were 
discarded. Finally, from such data we created a data set described by values of 42 attributes 
(values of attributes #23-32 from Table II were given twice – for the primary and the 
secondary assessment).  
This data set was used to construct prediction models and to evaluate their 
performance, where final severity of exacerbation verified through follow-up and 
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independent chart review was used as the gold standard. We considered the following 
prediction models constructed using machine learning techniques (these are models often 
considered in clinical problems [24]) and implemented by the WEKA system (version 3.6) 
[25]:  A naive Bayes model (denoted as NB),  A decision tree model (denoted as DT)  An ensemble of decision tree models (denoted as E-DT),  A support vector machine model (denoted as SVM)  An instance-based model with 1 and 10 nearest neighbours (denoted as IB1 and 
IB10 respectively). 
Decision trees in the DT and E-DT models were constructed using the C4.5 
algorithm, their ensemble was built using a bagging strategy, and SVM was developed using 
the SMO algorithm. Witten et al. [26] provide a comprehensive and detailed description of 
algorithms and techniques applied in constructing relevant prediction models (the reader is 
particularly referred to Chapter 4, 6 and 8). For all prediction models we used default values 
of parameters provided by WEKA (only for the SVM model we used calibrated parameter 
values to ensure proper probability estimates for AUC). In a preliminary experiment we 
checked the preprocessing techniques proposed by Farion et al. [10], however, their 
usefulness when applied to prospective data turned out to be negligible, therefore we finally 
did not consider them. 
All models were evaluated using the 10-fold cross validation scheme [26] – for more 
reliable results cross validation was repeated 10 times. We used AUC – area under the ROC 
curve [11] – as the primary evaluation criterion. The ROC curve is obtained by plotting 
sensitivity versus (1 – specificity) (we assumed moderate/severe category to be the positive 
class, and mild to be the negative one), and AUC measures how well the prediction model 
separates the classes and captures the trade-off between sensitivity and specificity. We also 
considered prediction accuracy as the secondary criterion.  
Finally, we selected a prediction model that had the best AUC and prediction 
accuracy. In order to check if differences in performance between specific models were 
statistically significant, we used a paired Student’s t-test. In this test we considered all 
possible pairs of prediction models and averaged results obtained by these models in 
individual folds. Evaluation and comparison of prediction models, including statistical tests 
were conducted using WEKA (version 3.6).  
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3.2.2. Phase 2 
Phase 2 took place from February 2009 to March 2010, and similarly to phase 1, it 
was a prospective observational data collection. However instead of paper forms, physicians 
used a mobile system – MET3-AE – to record and collect patient information. The data 
collection was combined with another study conducted in the ED which aimed to evaluate the 
usability of MET3-AE and assess the motivation of physicians to use computer-based support 
at the point of care. The MET3-AE system and its use in our study are briefly described in 
Section 3.4.  
Physicians collected information on patient history and current exacerbation, and 
results of primary and secondary assessments. Unlike in phase 1, a single observer 
approached each patient. This decision was dictated by the fact that it would be very difficult 
to have the same multiple observers doing patient reassessments. Each collected record was 
audited and patient follow-up was conducted similarly to phase 1 to establish a final 
exacerbation severity assessment that was considered as the gold standard for performance 
evaluation. 
The collected data set was preprocessed to obtain the structure consistent with the 
data set from phase 1. For each patient we retained two assessments– the primary assessment 
and a secondary assessment closest to the time point calculated in phase 1. 
Finally, we evaluated predictive performance of the selected prediction model, the 
PRAM score, and physicians by comparing their predictions to the gold standard (in the case 
of the PRAM score we used the threshold described in Section 3.3 to translate the total score 
into an exacerbation severity level).  Due to the requirements of the AUC measure (numerical 
probability estimates) we were not able to calculate the AUC for physicians, therefore in 
phase 2 we decided to use sensitivity and specificity instead. These measures were 
supplemented with the overall prediction accuracy and with positive and negative prediction 
values (PPV and NPV respectively).  
To check if there were statistically significant differences between predictions made 
by the selected model, the PRAM score, and physicians, we used the McNemar’s test [27] 
implemented in the R system (version 2.14) [28]. In this test we considered all possible pairs 
of predictors, and for each patient record we compared predictions made by the selected 
predictors (NB model – PRAM, NB model – physician, PRAM – physician). As we 
considered individual records instead of their sets (folds) in this phase, we were not able to 
obtain numerical outcomes for specific records, thus the Student’s t-test was not applicable. 
Page 11 of 24 
 
3.3. PRAM score  
The PRAM score was developed to assess asthma exacerbation severity among 
preschool-aged patients [29]. A subsequent prospective validation study demonstrated 
excellent performance for school-aged children as well [13], making it a reliable evaluation 
tool for the entire pediatric population. The PRAM score relies on a set of five clinical 
attributes (observations and tests) and it maps values of these attributes into a 4-point scale. 
Values of all attributes are required to calculate the score. 
While the PRAM score is primarily meant to monitor patient state over time (change 
in the score reflects changes in airway obstruction), it can be used to categorize the severity 
of asthma exacerbations with the following thresholds: total score between 0-4 indicating 
mild exacerbation, total score between 5-8 indicating moderate exacerbation, and total score 
between 9-12 indicating severe exacerbation [7]. Following its evaluation, the authors of the 
score concluded that PRAM is a responsive but only moderately discriminative score [29]. As 
a result, revised thresholds have been adopted in the ED of CHEO. These revised thresholds 
for the total PRAM score are: 0-3 – mild exacerbation, 4-7 – moderate mild exacerbation, and 
8-12 – severe exacerbation. In the our study we used these revised thresholds for the PRAM 
score when predicting asthma exacerbation severity, thus a total score between 0 and 3 was 
interpreted as mild exacerbation, and a score of 4 or above was translated into the 
moderate/severe exacerbation. 
3.4. MET3-AE system 
The MET3-AE system is a clinical decision support system for supporting 
management of pediatric asthma exacerbations [30]. Wilk et al. [31] described the design of 
MET3-AE system, and Sayyad Shirabad et al. [32] described its implementation. The system 
runs on desktop computers and mobile devices including tablets, and interacts with hospital 
information systems using HL7 messages. Diagnostic capabilities of MET3-AE are provided 
by a dedicated prediction model. In this paper we describe the research behind development 
and evaluation of this model (including a number of computational experiments). 
MET3-AE was piloted in the ED at CHEO in order to assess its usability and to learn 
about the motivation of physicians to use computerized support at the point of care [33]. We 
used this pilot to prospectively collect patient data using MET3-AE. Due to restrictions 
imposed by the CHEO Research Ethics Board, the diagnostic support function of the system 
was unavailable to physicians, thus the system acted as a mobile electronic patient chart. The 
version of MET3-AE used in the pilot was expanded by adding: 
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 A screen to record and evaluate eligibility criteria (i.e., inclusion and exclusion criteria 
from Table I),  A function to automatically compute and store the PRAM score for each recorded 
assessment,  A function to record and store predictions of exacerbation severity (mild or 
moderate/severe) made by a physician during each assessment,  A helper application to support patient record audit and follow-up in order to establish 
verified exacerbation severity. 
4. Results 
4.1. Results of phase 1 
4.1.1. Collected data 
Physicians approached 472 patients deemed potentially eligible at nursing triage. 
From this number, after subsequent assessment, they excluded 83 patients. From the 
remaining 389 eligible patients, 98 patients were excluded because of insufficient data 
recorded on paper forms (missing history or triage assessment). This produced a data set with 
291 records. During preprocessing we established that the average time point for the first 
secondary assessment was 82 minutes after the primary assessment and the standard 
deviation was 48 minutes. Thus, for each record we selected the secondary assessment that 
was located within the time window of 34-130 minutes and was closest to its middle point. 
Records with no secondary assessment in the time window were excluded. This eliminated 51 
records and the final set comprised 240 patient records, each described by 42 attributes 
corresponding to the patient’s history, current asthma exacerbation, primary assessment and a 
selected secondary assessment. The average age of patients in the final set was 6.0 years 
(standard deviation of 4.0 years), and 131 (54.6%) of them suffered from moderate/severe 
exacerbation. 
4.1.2. Selected prediction model 
Results obtained by cross validation for all evaluated prediction models are given in 
Table III. In terms of AUC, the best performance was achieved by the NB model (AUC of 
0.74). The difference between this model and the E-DT model (AUC of 0.70) was not 
statistically significant, while the differences between the NB model and the remaining 
models were statistically significant. The NB model also had the best predictive accuracy 
(68.0%). Differences between the NB model and the E-DT and IB10 models (prediction 
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accuracy of 64.1% and 63.6% respectively) were not statistically significant, and for the 
remaining models the differences were statistically significant. 
According to these results the two best performing models are NB and E-DT 
(contrary to our expectations, the single DT didn’t perform as well as in our earlier 
retrospective study [10]). We decided to select the NB model due to its simpler structure. 
This decision was further supported by Sajda [34] who discussed the advantages of methods 
based on Bayesian reasoning in the context of biomedical decision making, including the 
ability to deal with noisy and incomplete data.  
4.2. Results of phase 2 
4.2.1. Collected data 
Physicians approached 129 patients deemed potentially eligible by automatic parsing 
of HL7 admission messages. From this number, after subsequent assessment they excluded 
16 patients. From the remaining 113 eligible patients, 11 patients were excluded during audit 
and follow-up (inability to verify disposition decision or questionable data) and an additional 
20 patients were eliminated because of a lack of some data required for calculating a PRAM 
score. This produced a final data set comprised of 82 patients and this set was used to conduct 
comparative evaluations of the NB model, PRAM score, and physicians’ predictions. The 
average age of patients in the final set was 4.9 years (standard deviation of 3.5 years), and 56 
(68.3%) of them suffered from moderate/severe exacerbation. 
4.2.2. Predictive performance 
The predictions made by the NB model, the PRAM score, and physicians are 
presented in Table IV (confusion matrix) and Table V (performance indicators). While all 
performed almost identically when predicting a mild asthma exacerbation – the only 
difference being 1 misclassified patient by the NB model, the difference was more 
pronounced with the moderate/severe category – the NB model and the PRAM score 
misclassified 5 and 4 more patients than the physicians, respectively.  
While the physicians demonstrated better performance than the NB model and the 
PRAM score, according to the McNemar’s tests we were not able to state that the differences 
between outcomes in pairs of the predictors were statistically significant. 
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5. Discussion 
5.1. General remarks 
The NB model predicted the severity of asthma exacerbations (mild vs. 
moderate/severe) comparably to the PRAM score, but not as well as physicians (accuracy of 
70.7% vs. 73.2 vs. 78.0%, respectively). Specifically, the NB model and PRAM score 
underestimated severity (see Table V), while the physicians were better when identifying 
moderate/severe asthma patients. A plausible explanation for such a situation might be that 
predicting moderate/severe asthma needs more than reliance on basic symptoms, signs and 
tests and involves to a greater extent physicians’ tacit knowledge that is not captured in the 
scores or prediction models. However, we were not able to show that these differences in 
predictive performance were statistically significant. 
Despite differences in the study designs (setting different than ED, prediction of 
asthma severity instead of exacerbation severity) results produced by the NB model in phase 
2 compare favorably with results reported in related studies. The NB model was more 
accurate than the system for asthma management described by Hoeksema et al. [18] (70.7% 
vs. 63.0%) and the ADEMA system [23] (70.7% vs. 61.0%). Such performance of the NB 
model is encouraging.  
5.2. Limitations of the study 
Any prospective study conducted in the ED is difficult to design as it interrupts the 
workflow by requiring physicians to perform additional tasks while carrying on with regular 
patient management. The setting and associated study design ramifications did not allow us to 
carry out direct observation of physicians doing data collection and making prediction 
decisions. We also left patient enrollment entirely to the discretion of the attending 
physicians, and we did not prompt them to enroll even when parsing HL7 messages identified 
eligible patients.  
During phase 2, only one observer saw each patient. We have discussed this decision 
in Section 3.2.2. Moreover, the experiment did not follow the randomized controlled trial 
design and was confined to a single pediatric center (there are three pediatric academic 
centers in the Province of Ontario, and CHEO is one of them). This was because of the nature 
of the primary study involving MET3-AE and its usability assessment.  
Finally, phase 2 of the study was conducted only in an academic center. A true value 
provided by a prediction model should be assessed in the community or small hospitals, 
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where physicians may not be as experienced and comfortable in assessing the pediatric 
population.  
5.3. Implications and future research 
Using data collected during phase 2, we are continuing to work on improving the 
predictive performance of the NB model. Such a model should perform better in predicting 
moderate/severe asthma exacerbations in order to become part of a system that is accepted by 
physicians. We expect that the model’s performance will be improved if the original set of 
attributes is augmented with those associated with tacit knowledge physicians’ use when 
assessing a patient. We are working on ways of capturing this knowledge for pediatric asthma 
exacerbations and subsequently codifying it for use in developing a prediction model.  
Although our study was conducted in an academic hospital, we feel that the most 
important setting for this type of evaluation will be in the ED of community or small 
hospitals. If proven successful in such a setting, the NB model and similar prediction models 
should have true impact on improving the quality of care delivered to pediatric asthma 
patients. 
6. Conclusions 
The NB model was the best performing prediction model among those considered in 
phase 1. It demonstrated the best performance in terms of AUC and the observed differences 
were in most cases statistically significant. Therefore, it was selected for comparison with the 
PRAM score and physicians in phase 2. 
In light of the relatively close performance of the NB model and the PRAM score, it 
is possible to argue about the gains in flexibility when using a prediction model like NB 
instead of a score. This is because the NB model can be applied to incomplete patient data 
while a medical score cannot (note that we had to exclude 20 patients from the study because 
we did not have sufficient data to calculate PRAM score). In summary, the NB model shows 
promise in predicting the severity of asthma exacerbations but needs further research to 
improve the accuracy of predictions and to further verify it on a larger data set. In light of the 
model’s ease of use, it can be considered as a tool to use in conjunction with established 
medical scores, such as the PRAM score.  
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Clinical relevance statement 
Evaluation of predictive abilities of a prediction model, medical score, and human 
specialist using prospectively collected data is rarely reported in the literature, but results of 
such evaluations are important for developing clinical decision support systems. While the 
study reported here showed that physicians working in an academic hospital were better at 
predicting pediatric asthma exacerbations than the PRAM score or a machine-learning 
prediction model (the NB model), the performance of the latter two was very close. 
Considering that the use of the NB model does not require knowing values for all clinical 
attributes, such a model can be considered as an adjunct to clinical scores routinely used in 
asthma management. 
Protection of human and animal subjects 
The study was performed in compliance with the World Medical Association 
Declaration of Helsinki on Ethical Principles for Medical Research Involving Human 
Subjects, and was approved by the CHEO Ethics Review Board. 
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Table I. Inclusion and exclusion criteria used in the study 
Inclusion criteria (all of) 
1. Patient age between 1 and 17 years. 
2. Pre-existing diagnosis of asthma or reactive airways disease. Patients must have been previously 
prescribed inhaled bronchodilator therapy for one previous episode of wheeze, cough, or shortness-of-
breath. 
3. Presenting complaint of wheeze, cough, shortness-of-breath, or difficulty breathing requiring 
bronchodilator therapy in the ED. 
Exclusion criteria (any one of ) 
1. Patients receiving oral steroids chronically for asthma or any other illness, or for more than 48 hours 
prior to their ED visit for an acute exacerbation. 
2. Patients presenting for medication refills or other non-urgent reasons related to asthma, and not 
requiring ED treatment. 
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Table II. Clinical attributes characterizing a pediatric asthma exacerbation 
# Attribute Values 
Medical history 
1 Age at registration numerical (years) 
2 Primary care family doctor, pediatrician, walk-in/other, none 
3 Previous chest clinic assessment yes, no 
4 Age of first asthma symptoms < 1 year, 1-3 years, > 3 years 
5 Current inhaled steroids < 1 week, 1-4 weeks, > weeks, none 
6 Last exacerbation < 1 month ago, 1-3 months ago, 3-12 months ago, > 12 
months ago 
7 Last oral steroids < 1 month ago, 1-3 months ago, 3-12 months ago, > 12 
months ago, never 
8 Previous ED visits for asthma 1, 2, 3, 4 or more, none 
9 Previous admission for asthma floor, ICU, none 
10 Smokers at home/daycare yes, no 
11 Carpets in bedroom yes, no 
12 Pet allergies yes, no 
13 Food allergies yes, no 
14 Environmental allergies yes, no 
15 Atopy/eczema yes, no 
16 Family history of asthma yes, no 
Current exacerbation 
17 Duration of symptoms < 12 hours, 12-48 hours, >48 hours 
18 URTI symptoms yes, no 
19 Fever yes, no 
20 Exposure to allergen yes, no 
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# Attribute Values 
21 Bronchodilators in the last 24 hours 1-3, 4-6, > 6, none 
22 Transport to ED self/parents, ambulance 
Assessment (primary or secondary) 
23 SaO2 (oxygen saturation) numerical (%) 
24 Temperature numerical (C) 
25 Heart rate numerical (bpm) 
26 Respiratory rate numerical (bpm) 
27 Skin color pink/normal, dusky, pale 
28 Distress none, mild, moderate, severe 
29 Suprasternal retractions absent, present 
30 Scalene retractions absent, present 
31 Air entry normal, diminished at bases, diminished at widespread, 
minimal 
32 Wheezing absent, expiration, inspiration/expiration, audible with a 
stethoscope 
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Table III. Performance indicators for evaluated prediction models (95% CI); NB = naive 
Bayes model, DT = decision tree model, EDT = ensemble of decision trees models, SVM = 
support vector machine model, IB1, IB10 = instance-based model with 1 and 10 nearest 
neighbors respectively 
 Model 
 NB DT EDT SVM IB1 IB10 
AUC 0.74 
(0.73, 0.76) 
0.59 
(0.57, 0.62) 
0.70 
(0.68, 0.72) 
0.63 
(0.61, 0.65) 
0.56 
(0.54, 0.58) 
0.68 
(0.66, 0.70) 
Accuracy [%] 68.0 
(66.4, 69.6) 
60.9 
(59.1, 62.7) 
64.1 
(62.4, 65.8) 
59.2 
(57.3, 61.1) 
56.3 
(54.2, 58.3) 
63.6 
(61.7, 65.4) 
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Table IV. Confusion matrix: predictions of the NB model, PRAM score, and physicians 
 Predicted severity 
 NB model PRAM score Physicians 
Confirmed severity Mild Moderate/severe Mild Moderate/severe Mild Moderate/severe 
Mild 19 7 20 6 20 6 
Moderate/severe 17 39 16 40 12 44 
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Table V. Performance indicators for the NB model, PRAM score, and physicians’ predictions 
(95% CI); PPV = positive predictive value, NPV = negative predictive value 
 NB model PRAM score Physicians 
Accuracy [%] 70.7 (60.9, 80.6) 73.2 (63.6, 82.8) 78.0 (69.1, 87.0) 
Sensitivity 0.70 (0.58, 0.82) 0.71 (0.60, 0.83) 0.79 (0.68, 0.89) 
Specificity 0.73 (0.56, 0.90) 0.77 (0.61, 0.93) 0.77 (0.61, 0.93) 
PPV 0.85 (0.74, 0.95) 0.87 (0.77, 0.97) 0.88 (0.79, 0.97) 
NPV 0.53 (0.36, 0.69) 0.56 (0.39, 0.72) 0.63 (0.46, 0.79) 
 
 
